Cargando…

Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials

IMPORTANCE: In clinical trials supporting the regulatory approval of oncology drugs, solid tumor response is assessed using Response Evaluation Criteria in Solid Tumors (RECIST). Calculation of RECIST-based responses requires sequential, timed imaging data, which presents challenges to the method’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feinberg, Bruce A., Zettler, Marjorie E., Klink, Andrew J., Lee, Choo H., Gajra, Ajeet, Kish, Jonathan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907955/ https://www.ncbi.nlm.nih.gov/pubmed/33630085 http://dx.doi.org/10.1001/jamanetworkopen.2020.36741

Ejemplares similares

Impact of social determinants of health on cancer care: a survey of community oncologists
por: Zettler, Marjorie E, et al.
Publicado: (2021)

Expanded Access and Right To Try Requests: The Community Oncologist's Experience
por: Zettler, Marjorie E., et al.
Publicado: (2021)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

A Letter in Support of Real-World RECIST
por: Gajra, Ajeet, et al.
Publicado: (2020)

PRS30 COVID-19 RAPID Antigen Test False Positives and False Negatives Reported to the FDA Manufacturer and User Facility Device Experience Database
por: Zettler, M., et al.
Publicado: (2021)

Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting
por: Gajra, Ajeet, et al.
Publicado: (2022)

PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials
por: Aridgides, Paul, et al.
Publicado: (2011)

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study
por: Shammo, Jamile, et al.
Publicado: (2022)

Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
por: Gajra, Ajeet, et al.
Publicado: (2022)

Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
por: Nomura, Motoo, et al.
Publicado: (2020)

Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion Cancer
por: Klink, Andrew J., et al.
Publicado: (2022)

Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists
por: Klink, Andrew J, et al.
Publicado: (2022)

Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors
por: Zhang, Lei, et al.
Publicado: (2020)

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
por: Cobain, Erin F., et al.
Publicado: (2021)

Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
por: Mougalian, Sarah S., et al.
Publicado: (2021)

Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
por: Mougalian, Sarah S., et al.
Publicado: (2021)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
por: Montoya, Roberto C., et al.
Publicado: (2012)

Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States
por: Kish, Jonathan K., et al.
Publicado: (2020)

Clinical characteristics and associations of palmoplantar pustulosis: an observational study()()
por: Oktem, Ayse, et al.
Publicado: (2020)

Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials
por: Hu, Chen, et al.
Publicado: (2021)

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis
por: Tsakok, Teresa, et al.
Publicado: (2019)

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
por: Savill, Kristin M Zimmerman, et al.
Publicado: (2023)

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial
por: Blayney, Douglas W., et al.
Publicado: (2022)

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study
por: Parhofer, Klaus G, et al.
Publicado: (2007)

Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk
por: Xu, Xue, et al.
Publicado: (2019)

Comparison of Work Patterns Between Physicians and Advanced Practice Practitioners in Primary Care and Specialty Practice Settings
por: Rotenstein, Lisa S., et al.
Publicado: (2023)

Association of Clinical and Demographic Characteristics With Response to Electroconvulsive Therapy in Mania
por: Popiolek, Katarzyna, et al.
Publicado: (2022)

Initial Clinical Experience with (90)Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
por: Saad, Nibal, et al.
Publicado: (2017)

Prospective Comparison of Medical Oncologists and a Machine Learning Model to Predict 3-Month Mortality in Patients With Metastatic Solid Tumors
por: Zachariah, Finly J., et al.
Publicado: (2022)

Quantitative Genetics of Genomic Imprinting: A Comparison of Simple Variance Derivations, the Effects of Inbreeding, and Response to Selection
por: Santure, Anna W., et al.
Publicado: (2011)

Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors
por: Crook, Timothy, et al.
Publicado: (2020)

Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net Clinics
por: Carroll, Allison J., et al.
Publicado: (2023)

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting
por: Mougalian, Sarah S., et al.
Publicado: (2018)

Comparison of basal cell carcinoma subtypes observed in preoperative biopsy and Mohs micrographic surgery()()
por: Cerci, Felipe Bochnia, et al.
Publicado: (2020)

Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023)

Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors
por: Shao, Changxia, et al.
Publicado: (2020)

Reducing Avoidable Emergency Visits and Hospitalizations With Patient Risk-Based Prescriptive Analytics: A Quality Improvement Project at an Oncology Care Model Practice
por: Gajra, Ajeet, et al.
Publicado: (2023)

Concordance Between Electronic Clinical Documentation and Physicians’ Observed Behavior
por: Berdahl, Carl T., et al.
Publicado: (2019)

Association of Early Introduction of Solids With Infant Sleep: A Secondary Analysis of a Randomized Clinical Trial
por: Perkin, Michael R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g8egs4dvobiq8pkhua1frncfdb